Other News To Note
Thursday, June 7, 2012
Enamine Ltd., of Kiev, Ukraine, signed a collaboration agreement with the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge, UK, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB) in Prague, Czech Republic, to discover rhomboid protease inhibitors as potential drugs to treat infectious, parasitic, oncological, immune and cardiovascular diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.